Until January 2018, Dr Gerhardt Attard was a Cancer Research UK Clinician Scientist at the ICR and Consultant Medical Oncologist at The Royal Marsden. His main research interest is the development of novel therapeutics and biomarkers for castration-resistant prostate cancer (CRPC).
Dr Attard is an experienced clinical trialist in CRPC and is a co-author of more than 100 peer-reviewed manuscripts, including several important papers on advanced prostate cancer.
Dr Attard’s many awards over the years include the ASCO Foundation Annual Merit Award in 2007, Prostate Cancer Foundation Young Investigator Award in 2008, the AACR-GlaxoSmithKline Outstanding Clinical Scholar Award in 2009, the Medical Research Society/Academy of Medical Sciences Sue McCarthy Prize in 2010 and the McElwain award in 2010. Dr Attard sits on a number of advisory boards and the editorial board of Annals of Oncology as an associate editor.
Dr Attard's full bio
Dr Gerhardt key publications